http://www.acastipharma.com
Acasti Pharma Inc. Company Intro
Acasti Pharma is a biopharmaceutical innovator advancing a potentially best-in-class cardiovascular drug, CaPre® (omega-3 phospholipid), for the treatment of hypertriglyceridemia, a chronic condition affecting an estimated one third of the…
Industry
Healthcare
Acasti Pharma Inc. Headquaters
545, Promenade du Centropolis
Laval,H7T 0A3
Canada
Acasti Pharma Inc. Share price
17 May 2023 12:43 GMT
$0.4900
0.0 (0.95 %)
Acasti Pharma Inc. Market cap
$22.976 M
WMC RANKING
2023
Acasti Pharma Inc. # 314
BiotechnologyLatest Acasti Pharma Inc. News
21 Sep 2023
Where Does Acasti Pharma Inc (ACST) Stock Fall in the Biotechnology Field After It Is Down -2.99% This Week?
Acasti Pharma Inc (ACST) is near the top in its industry group according to InvestorsObserver. ACST gets an overall rating of 57.
21 Sep 2023
Where Does Acasti Pharma Inc (ACST) Stock Fall in the ...
ACST gets an overall rating of 57. That means it scores higher than 57 percent of stocks. Acasti Pharma Inc gets a 79 rank in the Biotechnology industry.
17 Sep 2023
Hypertriglyceridemia Treatment Market 2023 Report ...
Additionally, the report focuses on a thorough analysis of key players, including [ Catabasis Pharmaceuticals Inc, Jeil Pharmaceutical Co Ltd, AstraZeneca Plc,...
WMC Market Score
WMC Market to Revenue Score
Acasti Pharma Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Acasti Pharma Inc. | USD | $196 | $10,836 | $-19,678 | $230M | 314 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $144,340B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Acasti Pharma Inc. Social Followers vs Top 4 Industry Competitors
Acasti Pharma Inc. Post vs Top 4 Industry Competitors
Acasti Pharma Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Acasti Pharma Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Acasti Pharma Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Acasti Pharma Inc. | 0.00 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 28 | 0 | 0 | 29.94 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 40 | 0 | 0 | 36.32 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 32 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 45.31 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
